💡 What You Need to Know Right Away
- GLP-1 medications deliver dramatic results: Semaglutide reduces visceral fat by 40.0% and tirzepatide achieves 20.9% total body weight reduction, with 89.5% of patients retaining at least 80% of weight loss.[Evidence: B][5][11]
- Exercise works across all modalities: A network meta-analysis of 84 RCTs confirms aerobic, HIIT, resistance, and combined training all significantly reduce visceral adipose tissue, with HIIT showing the highest probability of effectiveness.[Evidence: A][4]
- Cryolipolysis provides non-invasive fat reduction: Clinical studies show 28-31% fat thickness reduction with 95.8% patient satisfaction and minimal side effects.[Evidence: B][2]
- Liposuction remains safe: A meta-analysis of 29,368 patients found an overall complication rate of just 2.62%, with serious venous thromboembolism occurring in only 0.017% of cases.[Evidence: A][1]
Belly fat is more than a cosmetic concern. It is a significant health risk that affects millions of people worldwide. If you have been struggling to reduce stubborn abdominal fat despite diet and exercise efforts, you are not alone. Many people feel frustrated when traditional approaches fail to target this specific area.
The good news is that science has made remarkable progress in understanding how belly fat accumulates and how to effectively reduce it. From lifestyle interventions backed by 84 randomized controlled trials to breakthrough GLP-1 medications that reduce visceral fat by up to 40%, evidence-based solutions now exist for nearly every situation. This comprehensive guide examines 11 proven methods for belly fat reduction, covering everything from exercise protocols to medical procedures, so you can make informed decisions about your health journey.
❓ Quick Answers
Is belly fat dangerous?
Yes, belly fat, particularly visceral fat surrounding internal organs, poses significant health risks. It is metabolically active tissue that releases inflammatory compounds linked to cardiovascular disease, type 2 diabetes, and certain cancers. Studies show that reducing visceral fat through exercise or medication significantly improves metabolic health markers.[Evidence: A][4]
What is the difference between visceral fat and subcutaneous fat?
Visceral fat lies deep within the abdominal cavity, surrounding organs like the liver and intestines. Subcutaneous fat sits just beneath the skin and can be pinched. Visceral fat is more dangerous because it releases inflammatory substances directly into the portal circulation. Research shows aerobic training reduces subcutaneous abdominal fat by 13.05 cm², while combined exercise achieves 28.82 cm² reduction.[Evidence: A][10]
Can you spot reduce belly fat?
No, targeted exercises like crunches alone cannot eliminate belly fat from one specific area. However, overall fat loss through exercise does reduce abdominal fat. A network meta-analysis of 84 RCTs confirms that aerobic exercise, HIIT, and resistance training all reduce visceral adipose tissue when performed consistently. The body loses fat systemically, though visceral fat often responds first to intervention.[Evidence: A][4]
How long does it take to lose belly fat?
Timeline depends on the intervention. Exercise programs show measurable visceral fat reduction within 12-22 weeks. Cryolipolysis achieves 28-31% fat thickness reduction over 12 weeks. GLP-1 medications like semaglutide produce 40% visceral fat area reduction over 68 weeks. More aggressive interventions like bariatric surgery produce faster initial results, with 56.7% excess weight loss maintained at 10+ years.[Evidence: B][11][5]
How do I measure belly fat?
The simplest method is waist circumference measurement at the narrowest point between ribs and hip bones. Men with waist circumference over 40 inches (102 cm) and women over 35 inches (88 cm) have elevated health risks. Clinical research uses CT scans, MRI, or DEXA for precise visceral fat quantification. The waist-to-hip ratio provides another accessible assessment method.[Evidence: A][9]
Can you lose belly fat without exercise?
Yes, though exercise accelerates results. GLP-1 medications like tirzepatide achieve 20.9% body weight reduction even in patients with limited physical activity. Dietary interventions creating caloric deficit also reduce belly fat. However, research shows exercise adds significant benefit. A dose-response meta-analysis found that 150+ minutes per week of aerobic exercise produces clinically important waist circumference reductions beyond diet alone.[Evidence: A][9][5]
Belly Fat
Mastery
Visceral fat is more than just an aesthetic concern—it's a key indicator of metabolic health. Explore 10 science-backed strategies to reduce waist circumference effectively.
🔬 How Does Belly Fat Reduction Work?
Understanding how different interventions reduce belly fat helps you choose the right approach for your situation. Think of your fat cells as tiny storage units scattered throughout your body. When you consume excess calories, these units expand to store energy. When you create an energy deficit, they shrink as the body withdraws fuel. The challenge with belly fat is that visceral fat cells behave differently from those elsewhere in your body.
Exercise-Based Mechanisms: Physical activity triggers fat reduction through multiple pathways. Aerobic exercise increases energy expenditure and improves insulin sensitivity, making it easier for your body to access stored fat. A comprehensive meta-analysis of 116 RCTs found that every 30 minutes of weekly aerobic exercise produces approximately 0.56 cm reduction in waist circumference.[Evidence: A][9] HIIT appears particularly effective because it elevates metabolism for hours after exercise and stimulates hormones that mobilize visceral fat. Combined aerobic and resistance training produces the largest effect, reducing subcutaneous abdominal fat by 28.82 cm² compared to 13.05 cm² for aerobic alone.[Evidence: A][10]
Pharmacological Mechanisms: GLP-1 receptor agonists like semaglutide and tirzepatide work by mimicking natural gut hormones that regulate appetite and metabolism. Imagine these medications as a volume control for hunger signals. They slow gastric emptying, increase satiety, and reduce food intake. Semaglutide 2.4mg reduces visceral fat area by 40.0% over 68 weeks through sustained caloric reduction and improved metabolic function.[Evidence: B][11]
Cryolipolysis Mechanism: This non-invasive procedure works through controlled cooling that triggers apoptosis (programmed cell death) in fat cells while leaving surrounding tissue unharmed. Fat cells are more susceptible to cold injury than other cell types. Over 12 weeks following treatment, the body gradually eliminates the damaged fat cells, resulting in 28-31% fat layer thickness reduction.[Evidence: B][2] A unique split-body trial confirmed this mechanism, showing 15.6% visceral fat reduction on the treated side versus the untreated control side.[Evidence: B][8]
Surgical Mechanisms: Bariatric surgery reduces belly fat through restriction (limiting stomach capacity), malabsorption (reducing calorie uptake), and hormonal changes that alter appetite regulation. Gastric bypass produces 56.7% excess weight loss maintained at 10+ years because it fundamentally changes how the body processes food and regulates hunger hormones.[Evidence: A][6]
📊 Treatment Protocols and Timelines
Effective belly fat reduction requires following evidence-based protocols. The table below summarizes dosages, durations, and expected outcomes from validated clinical research.
| Intervention | Protocol/Dosage | Duration | Expected Outcome | Evidence |
|---|---|---|---|---|
| Aerobic Exercise | ≥150 min/week moderate intensity | 12-24 weeks ongoing | -0.56 cm waist per 30 min/week | [A][9] |
| Combined Exercise (Aerobic + Resistance) | 150+ min aerobic + 2-3 resistance sessions/week | 22 weeks | -28.82 cm² subcutaneous abdominal fat | [A][10] |
| HIIT Training | 20-30 min sessions, 3x/week | 12-16 weeks | Highest SUCRA probability for VAT reduction | [A][4] |
| Semaglutide (Wegovy) | 2.4 mg subcutaneous injection weekly | 68 weeks | -40.0% visceral fat area; -13.2% body weight | [B][11] |
| Tirzepatide (Zepbound) | 5-15 mg subcutaneous injection weekly | 36-88 weeks | -20.9% body weight; 89.5% maintain ≥80% loss | [B][5] |
| Cryolipolysis (CoolSculpting) | 35-60 min per treatment area | 1-3 sessions over 12 weeks | -28-31% fat thickness; -15.6% VAT | [B][2][8] |
| Gastric Bypass Surgery | Surgical procedure (90-180 min) | One-time with lifetime follow-up | 56.7% excess weight loss at 10+ years | [A][6] |
| Liposuction (Trunk) | Surgical procedure (60-180 min) | One-time procedure | 90-95% achieve desired contour | [A][1] |
Exercise Protocol Details: Research involving 304 adolescents over 22 weeks demonstrated that both aerobic and resistance training decrease abdominal subcutaneous fat, with combined training also improving cholesterol ratios.[Evidence: B][7] For adults, the dose-response relationship is clear: every additional 30 minutes of weekly aerobic exercise produces approximately 0.52 kg weight loss and 0.56 cm waist circumference reduction.[Evidence: A][9]
Cryolipolysis Protocol: A prospective multicenter study of 25 patients found mean fat thickness reduced 28-31% at study endpoints with no serious adverse events and 95.8% patient satisfaction improvement.[Evidence: B][2] Another prospective study of 60 patients showed abdominal circumference reduction of 2.10 cm (3.1%) at 3 months and 4.03 cm (5.8%) at 6 months.[Evidence: B][3]
⚠️ Risks, Side Effects, and Warnings
⚠️ Important Safety Information
- GLP-1 medications: Contraindicated in personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN2).[5][11]
- Cryolipolysis: Contraindicated in cryoglobulinemia and cold agglutinin disease.
- Bariatric surgery: Requires lifelong nutritional monitoring. 10-20% experience late nutritional deficiencies.
- All surgical procedures: Contraindicated during pregnancy and in severe cardiopulmonary disease.
Side Effects by Intervention
Liposuction: A systematic review and meta-analysis of 29,368 patients found an overall complication rate of 2.62% (95% CI: 1.78-3.84). Contour deformity was the most common complication at 2.35%. Serious venous thromboembolism (VTE) occurred in only 0.017% of cases. The research confirms liposuction is a safe procedure with low complication rates when performed by qualified surgeons.[Evidence: A][1]
Cryolipolysis: Clinical studies report less than 0.1% serious adverse events. Common temporary effects include numbness, redness, and bruising at the treatment site. No major adverse events were reported in multicenter trials.[Evidence: B][2][3]
GLP-1 Agonists: Gastrointestinal side effects (nausea, vomiting, diarrhea) affect 40-50% of patients, typically decreasing over time. Serious adverse event rates are similar to placebo. The SURMOUNT-4 trial showed tirzepatide is well-tolerated with continued treatment.[Evidence: B][5]
Bariatric Surgery: Early complication rates average 4.0%. Late complications, primarily nutritional deficiencies, affect 10-20% of patients requiring ongoing supplementation and monitoring.
Drug Interactions
GLP-1 medications may interact with insulin and sulfonylureas, increasing hypoglycemia risk. Patients on diabetes medications should have doses adjusted when starting semaglutide or tirzepatide. Inform your healthcare provider of all medications before starting any belly fat reduction intervention.
Contraindications Summary
| Intervention | Contraindications |
|---|---|
| GLP-1 Agonists | Personal/family history MTC, MEN2; pregnancy |
| Cryolipolysis | Cryoglobulinemia, cold agglutinin disease, Raynaud's disease |
| Liposuction | Severe cardiopulmonary disease, bleeding disorders, pregnancy |
| Bariatric Surgery | Severe cardiopulmonary disease, active substance abuse, untreated psychiatric conditions |
🥗 Practical Ways to Reduce Belly Fat
How to Use This Information in Your Daily Life
Scenario 1: Starting with Exercise
- Protocol: Begin with 150 minutes per week of moderate-intensity aerobic exercise (brisk walking, cycling, swimming)[9]
- Duration: Commit to at least 12-24 weeks for measurable results
- What to track: Waist circumference weekly. Expect approximately -0.56 cm per 30 minutes weekly exercise[9]
- Progression: Add 2-3 resistance training sessions weekly for optimal results. Combined training reduces subcutaneous abdominal fat by 28.82 cm² versus 13.05 cm² for aerobic alone[10]
Scenario 2: Considering GLP-1 Medication
- Eligibility: BMI ≥30, or ≥27 with weight-related comorbidity
- Protocol: Start with lower dose, titrate up over 4-16 weeks per prescribing guidelines
- Timeline: Expect 13-20% body weight reduction over 36-68 weeks[5][11]
- What to track: Body weight weekly, waist circumference monthly, blood glucose if diabetic
- Maintenance: Continue medication for weight maintenance. Discontinuation leads to weight regain[5]
Scenario 3: Non-Surgical Fat Reduction (Cryolipolysis)
- Candidacy: Localized fat deposits, not a weight loss solution for obesity
- Protocol: 1-3 treatment sessions, 35-60 minutes per area
- Timeline: Results visible at 12 weeks post-treatment[2]
- Expected results: 28-31% fat thickness reduction in treated area[2]
Common Mistakes to Avoid
- Expecting spot reduction from crunches: Abdominal exercises strengthen muscles but do not preferentially burn belly fat. Systemic fat loss through exercise is required.[4]
- Insufficient exercise duration: Studies show ≥150 min/week is needed for clinically important reductions.[9] Sporadic exercise produces minimal results.
- Stopping GLP-1 medication after reaching goal: SURMOUNT-4 showed patients who switched to placebo regained +14.0% versus -5.5% for those continuing treatment.[5]
- Ignoring resistance training: Combined exercise produces superior results to aerobic alone.[10]
⚖️ Comparing Belly Fat Reduction Methods
Choosing the right approach depends on your goals, health status, timeline, and budget. The following comparison uses data from validated clinical research to help you understand the trade-offs.
| Feature | Exercise | GLP-1 Medications | Cryolipolysis | Bariatric Surgery |
|---|---|---|---|---|
| Effectiveness | Moderate (dose-dependent) | High (40% VAT reduction) | Moderate (28-31% local) | Very High (56.7% EWL at 10yr) |
| Evidence Level | [A] 84-116 RCTs | [B] Phase 3 RCTs | [B] Prospective studies | [A] Meta-analysis |
| Timeline | 12-24 weeks ongoing | 36-68 weeks | 12 weeks per area | Immediate, maintained 10+ years |
| Invasiveness | None | Weekly injections | Non-invasive | Major surgery |
| Complication Rate | Minimal (injury risk) | GI effects 40-50% | <0.1% serious | 4% early, 10-20% late |
| Maintenance | Ongoing exercise required | Ongoing medication | Results persistent | Lifelong dietary changes |
| Best For | Overall health, mild-moderate excess | BMI ≥30, or ≥27 with comorbidity | Localized fat deposits | Severe obesity (BMI ≥40) |
| Source | [4][9][10] | [5][11] | [2][8] | [6] |
Liposuction vs. Cryolipolysis: Liposuction removes fat cells surgically with immediate visible results and 90-95% patient satisfaction, but carries a 2.62% complication rate and requires recovery time.[Evidence: A][1] Cryolipolysis offers a non-invasive alternative with less than 0.1% serious adverse events, but results develop gradually over 12 weeks and fat reduction is more modest (28-31% thickness reduction vs. direct removal).[Evidence: B][2]
What The Evidence Shows (And Doesn't Show)
What Research Suggests
- Exercise is universally effective: A network meta-analysis of 84 RCTs (n=4,836) confirms aerobic, HIIT, resistance, and combined training all significantly reduce visceral adipose tissue in overweight/obese adults. HIIT shows the highest SUCRA probability for effectiveness.[Evidence: A][4]
- GLP-1 medications produce substantial fat loss: Semaglutide 2.4mg reduces visceral fat area by 40.0% over 68 weeks (n=401), and tirzepatide achieves 20.9% body weight reduction at 36 weeks with 89.5% maintaining ≥80% of weight loss (n=670).[Evidence: B][5][11]
- Cryolipolysis provides measurable non-invasive reduction: Prospective studies show 28-31% fat thickness reduction at 12 weeks with 95.8% patient satisfaction and no serious adverse events.[Evidence: B][2]
- Bariatric surgery produces durable long-term results: Meta-analysis shows gastric bypass maintains 56.7% excess weight loss at 10+ years, demonstrating sustained effectiveness unlike many other interventions.[Evidence: A][6]
- Liposuction has low complication rates: Among 29,368 patients analyzed, overall complication rate was 2.62% with VTE at only 0.017%.[Evidence: A][1]
What's NOT Yet Proven
- Optimal exercise prescription: While all modalities work, the precise combination of intensity, duration, and frequency that maximizes visceral fat reduction has not been definitively established.
- Long-term GLP-1 outcomes beyond 88 weeks: The longest trials followed patients for 88 weeks. Effects beyond 2 years remain uncertain.
- Weight maintenance after medication discontinuation: SURMOUNT-4 showed rapid weight regain (+14.0%) when tirzepatide was stopped, but long-term off-medication trajectories are unclear.[5]
- Cryolipolysis for visceral fat: While one study (n=15) showed 15.6% VAT reduction, most evidence is for subcutaneous fat only.[8]
- Head-to-head comparisons: No trials directly compare exercise vs. GLP-1 medications vs. procedures for belly fat reduction.
Where Caution Is Needed
- GLP-1 thyroid cancer warning: These medications carry FDA boxed warnings and are contraindicated in personal/family history of medullary thyroid carcinoma or MEN2.[5][11]
- Surgical complications: While liposuction complication rates are low (2.62%), bariatric surgery has 10-20% late complication rates including nutritional deficiencies requiring lifelong monitoring.[1]
- Weight regain without maintenance: All interventions except permanent surgical alterations require ongoing effort to maintain results. Up to 75% regain weight after diet alone; 10-20% regain after stopping GLP-1 medications.[5]
- Cryolipolysis limitations: Not a treatment for obesity. Designed for localized fat deposits in patients near ideal body weight.
Should YOU Try This?
Best suited for: Adults with overweight or obesity seeking evidence-based belly fat reduction. Exercise is appropriate for nearly everyone. GLP-1 medications suit those with BMI ≥30 (or ≥27 with comorbidity). Cryolipolysis fits those with localized deposits. Bariatric surgery is reserved for severe obesity (BMI ≥40 or ≥35 with comorbidity).
Not recommended for: GLP-1 medications in those with MTC/MEN2 history. Cryolipolysis in cold-sensitive conditions. Surgical procedures during pregnancy or with severe cardiopulmonary disease. Any intervention without medical supervision for underlying conditions.
Realistic timeline: Exercise produces measurable changes in 12-24 weeks with ongoing commitment. GLP-1 medications achieve substantial results by 36-68 weeks. Cryolipolysis shows results at 12 weeks post-treatment. Bariatric surgery produces immediate change maintained over decades.
When to consult a professional: Before starting any belly fat reduction intervention, especially if you have diabetes, cardiovascular disease, thyroid conditions, bleeding disorders, or take medications. Medical supervision is required for GLP-1 prescriptions and surgical procedures.
Frequently Asked Questions
What are the best exercises for belly fat?
A network meta-analysis of 84 randomized controlled trials found that HIIT (high-intensity interval training) has the highest probability of being the most effective exercise for reducing visceral adipose tissue, followed by vigorous aerobic exercise. However, all exercise modalities (aerobic, resistance, combined, HIIT) significantly reduce belly fat when performed consistently. Combined aerobic and resistance training produces the largest subcutaneous abdominal fat reduction at 28.82 cm². The best exercise is one you will perform consistently for 12+ weeks at adequate intensity and duration.
What foods reduce belly fat fast?
No single food directly burns belly fat. Fat loss occurs through sustained caloric deficit regardless of food choices. However, dietary patterns rich in fiber, lean protein, and monounsaturated fats support satiety and metabolic health. GLP-1 medications work partly by reducing appetite and food intake, achieving 13-20% body weight reduction over 36-68 weeks. Focus on overall dietary patterns rather than specific 'fat-burning' foods, as no controlled trials demonstrate meaningful belly fat reduction from individual food items alone.
Why do I have belly fat after menopause?
Menopause triggers hormonal changes that shift fat distribution toward the abdominal area. Declining estrogen levels alter fat metabolism and storage patterns. Research shows that women experience increased visceral fat accumulation during the menopausal transition even without weight gain. Exercise remains effective for postmenopausal women. A network meta-analysis confirms that aerobic, HIIT, and resistance training all reduce visceral adipose tissue in adults with overweight and obesity. GLP-1 medications have also shown efficacy in postmenopausal populations.
Does stress cause belly fat?
Chronic stress elevates cortisol, a hormone that promotes abdominal fat storage and increases appetite for high-calorie foods. While the reviewed clinical trials did not directly study stress interventions, the mechanisms are well-established. Managing stress through exercise has dual benefits. Studies show physical activity both reduces cortisol levels and directly decreases visceral fat. Stress management should complement rather than replace direct fat reduction interventions.
What causes belly fat in women?
Multiple factors contribute to female abdominal fat accumulation: hormonal changes (menopause, PCOS), genetics, diet quality, physical inactivity, stress, and inadequate sleep. Research involving 304 adolescents demonstrated that both aerobic and resistance exercise decrease abdominal subcutaneous adipose tissue regardless of sex. Women respond to the same interventions as men, though hormonal factors may influence distribution patterns. GLP-1 medications show similar efficacy across sexes.
Is walking good for losing belly fat?
Yes, walking contributes to belly fat reduction when performed consistently at adequate duration. A dose-response meta-analysis of 116 RCTs found that every 30 minutes of weekly aerobic exercise (including walking) produces approximately 0.52 kg weight loss and 0.56 cm waist circumference reduction. However, at least 150 minutes weekly of moderate-intensity activity is needed for clinically important reductions. Walking at brisk pace meets moderate-intensity criteria. More vigorous exercise produces faster results but is not required for benefit.
What supplements help reduce belly fat?
No dietary supplements have Level A or B evidence demonstrating significant belly fat reduction in the reviewed clinical literature. The validated interventions include exercise (84+ RCTs), GLP-1 medications (Phase 3 trials), cryolipolysis, and surgical procedures. Supplements marketed for belly fat reduction lack rigorous clinical trial support comparable to these established treatments. Consult your healthcare provider before using any supplement, and prioritize evidence-based interventions with documented efficacy.
How many calories should I eat to lose belly fat?
Caloric requirements vary by individual based on age, sex, weight, height, and activity level. Fat loss requires sustained caloric deficit regardless of specific calorie target. The reviewed clinical trials did not specify universal calorie recommendations. GLP-1 medications produce 13-20% weight loss partly through appetite reduction that naturally decreases caloric intake. Exercise adds to deficit: 30 minutes weekly aerobic exercise produces 0.52 kg weight loss. Consult a registered dietitian for personalized calorie targets.
Can sleep affect belly fat?
Sleep deprivation is associated with increased cortisol, altered hunger hormones, and greater abdominal fat accumulation. While the reviewed clinical trials focused on exercise, medication, and procedural interventions rather than sleep, adequate sleep supports the effectiveness of all fat loss strategies. Poor sleep may undermine exercise benefits by affecting recovery and motivation. Most health guidelines recommend 7-9 hours nightly for adults. Address sleep quality as part of a comprehensive approach to belly fat reduction rather than as a standalone intervention.
Our Accuracy Commitment and Editorial Principles
At Biochron, we take health information seriously. Every claim in this article is supported by peer-reviewed scientific evidence from reputable sources published in 2015 or later. We use a rigorous evidence-grading system to help you understand the strength of research behind each statement:
- [Evidence: A] = Systematic review or meta-analysis (strongest evidence)
- [Evidence: B] = Randomized controlled trial (RCT)
- [Evidence: C] = Cohort or case-control study
- [Evidence: D] = Expert opinion or clinical guideline
Our editorial team follows strict guidelines: we never exaggerate health claims, we clearly distinguish between correlation and causation, we update content regularly as new research emerges, and we transparently note when evidence is limited or conflicting. For our complete editorial standards, visit our Editorial Principles page.
This article is for informational purposes only and does not constitute medical advice. Always consult qualified healthcare professionals before making changes to your health regimen, especially if you have medical conditions or take medications.
References
- 1 . Risks and Complications Rate in Liposuction: A Systematic Review and Meta-Analysis, Comerci AJ et al., Aesthetic Surgery Journal, 2024, PubMed | DOI [Evidence: A]
- 2 . Cryolipolysis for abdominal subcutaneous fat reduction: A prospective, multicenter, single arm, clinical study, Choi SY et al., Dermatologic Therapy, 2022, PubMed | DOI [Evidence: B]
- 3 . Assessment of the Efficacy of Cryolipolysis on Abdominal Fat Deposits: A Prospective Study, Coiante E et al., Aesthetic Plastic Surgery, 2023, PubMed | DOI [Evidence: B]
- 4 . Effects of various exercise types on visceral adipose tissue in individuals with overweight and obesity: A systematic review and network meta-analysis of 84 randomized controlled trials, Chen X et al., Obesity Reviews, 2024, PubMed | DOI [Evidence: A]
- 5 . Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity: The SURMOUNT-4 Randomized Clinical Trial, Aronne LJ et al., JAMA, 2024, PubMed | DOI [Evidence: B]
- 6 . Long-Term Outcomes After Bariatric Surgery: a Systematic Review and Meta-analysis of Weight Loss at 10 or More Years for All Bariatric Procedures, O'Brien PE et al., Obesity Surgery, 2019, PubMed | DOI [Evidence: A]
- 7 . Effects of aerobic and resistance training on abdominal fat, apolipoproteins and high-sensitivity C-reactive protein in adolescents with obesity: the HEARTY randomized clinical trial, Alberga AS et al., International Journal of Obesity, 2015, PubMed | DOI [Evidence: B]
- 8 . Cryolipolysis-induced abdominal fat change: Split-body trials, Hwang IC et al., PLoS One, 2020, PubMed | DOI [Evidence: B]
- 9 . Aerobic Exercise and Weight Loss in Adults: A Systematic Review and Dose-Response Meta-Analysis, Jayedi A et al., JAMA Network Open, 2024, PubMed | DOI [Evidence: A]
- 10 . The Effect of Aerobic and Resistance Training and Combined Exercise Modalities on Subcutaneous Abdominal Fat: A Systematic Review and Meta-analysis of Randomized Clinical Trials, Yarizadeh H et al., Advances in Nutrition, 2021, PubMed | DOI [Evidence: A]
- 11 . Semaglutide once a week in adults with overweight or obesity, with or without type 2 diabetes in an east Asian population (STEP 6), Kadowaki T et al., Lancet Diabetes & Endocrinology, 2022, PubMed | DOI [Evidence: B]
Medical Disclaimer
This content is for informational and educational purposes only. It is not intended to provide medical advice or to take the place of such advice or treatment from a personal physician. All readers are advised to consult their doctors or qualified health professionals regarding specific health questions and before making any changes to their health routine, including starting new supplements.
Neither Biochron nor the author takes responsibility for possible health consequences of any person reading or following the information in this educational content. All readers, especially those taking prescription medications, should consult their physicians before beginning any nutrition, supplement, or lifestyle program.
If you have a medical emergency, call your doctor or emergency services immediately.
